Healthcare -
Biotechnology - NASDAQ - US
$ 0.493
1.46 %
$ 28.6 M
Market Cap
-0.29
P/E
BCAB - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities BCAB - BioAtla, Inc.
77 K
LAST VALUE
-96.67%
2 YEAR CAGR
-56.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR